Healthy volunteer
Conditions
Interventions
Oral ingestion of the test product A(4 weeks)
Oral ingestion of the test product B(4 weeks)
Oral ingestion of the control product(4 weeks)
Sponsors
Anti-Aging Bank Co.,Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: [1]Japanese females aged 50-69 years [2]Healthy individuals not receiving any medical disease treatment [3]Individuals voluntarily join the study with written informed consent [4]Individuals who can have an examination on a designated check day [5]Individuals judged appropriate to join this study by principal investigators
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products [2]Individuals with skin disease,such as atopic dermatitis [3]Individuals who have an inflammation or a scar on a measuring area [4]Individuals under treatment or with history of mental disorders, sleep disorders,hypertension,diabetes,lipid metabolism abnormality,or other serious disorders [5]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache,menstrual pain,common cold,etc. [6]Individuals with history of serious diseases (hepatic,renal,cardiovascular,respiratory,hematologic,etc.) [7]Individual who have digestive organ disease [8]Individuals donated blood >200ml in past 1 month or >400ml in past 3 months [9]Individual who have experienced mood disorder or physical condition deterioration due to blood sampling in the past [10] Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [11]Currently,health food,supplements with continuous ingestion habits,individuals who intend to intake during the examination period (but not those who can stop taking the intake at the time of consent acquisition) [12]Individuals with alcohol intake exceeding 60g/day,as ethanol volume [13]Individuals who may significantly change exercise habit or lifestyle during the study period(ex. travel for a long time) [14]Pregnant or lactating women (expected,desired inclusive) [15]Individuals who will get sunburned during the test period etc. [16]Individuals participating or planning to join the other clinical investigations during the study period [17]Individual with potential conflict of interests [18]Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accumulation of AGEs(Fluorescent AGEs,CML, Pentosidine) | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety(Blood biochemistry etc.) | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co., Ltd. Department of Clinical Trial
Outcome results
None listed